ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 494,23
0,96%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Paratek Pharmaceuticals Inc (PRTK)

  7. Paratek Pharmaceuticals Inc (PRTK) Actualités

PRTK Paratek Pharmaceuticals Inc

2,23
0,00 (0,00%)
03 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Paratek Pharmaceuticals Inc PRTK NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 2,23 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
2,23 2,23
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
05/10/202314:00GLOBEParatek Pharmaceuticals to Present NUZYRA Data at IDWeek..
02/10/202313:33EDGAR2Form 15-12G - Securities registration termination [Section..
26/9/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
21/9/202319:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202319:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202319:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202319:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202319:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202319:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202319:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202319:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202319:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202319:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202319:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202319:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202316:59EDGAR2Form SC 13E3/A - Going private transaction by certain..
21/9/202316:42EDGAR2Form POS AM - Post-Effective amendments for registration..
21/9/202316:39EDGAR2Form S-8 POS - Securities to be offered to employees in..
21/9/202315:10EDGAR2Form 25-NSE - Notification filed by national security..
21/9/202315:07EDGAR2Form 8-K - Current report
21/9/202314:58GLOBEGurnet Point Capital and Novo Holdings A/S Complete..
18/9/202323:23EDGAR2Form SC 13E3/A - Going private transaction by certain..
18/9/202318:49EDGAR2Form 8-K - Current report
12/9/202323:08EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
12/9/202322:21EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
12/9/202322:19EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/9/202315:14EDGAR2Form SC 13E3/A - Going private transaction by certain..
11/9/202313:46EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/9/202313:42EDGAR2Form 8-K - Current report
07/9/202322:31EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
30/8/202322:31EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
22/8/202322:31EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
22/8/202322:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
18/8/202322:36EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
16/8/202322:50EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
14/8/202323:13EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/8/202302:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202302:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202302:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202302:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202302:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202320:37BWInvestor Alert: Abbott Cooper PLLC Announces Investigation..
03/8/202314:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202314:00GLOBEParatek Pharmaceuticals Announces Second Quarter 2023..
02/8/202323:28EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
02/8/202323:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
02/8/202323:03EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
28/7/202320:01EDGAR2Form SC 13E3/A - Going private transaction by certain..
28/7/202318:55EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
11/7/202322:15EDGAR2Form DEFA14A - Additional definitive proxy soliciting..

Dernières Valeurs Consultées

NASDAQ
PRTK
Paratek Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés